Table 2 Maternal and pregnancy outcomes in the study population.
From: Analysis of SARS-CoV-2 vertical transmission during pregnancy
Total study population n = 31 | |
|---|---|
Delivery mode | |
Vaginal, n (%) | 25 (81) |
Caesarean section, n (%) | 6 (19) |
GA at delivery, weeks median (range) | 39 (34.4–41.4) |
Induction of delivery related to COVID-19, n (%) | 6 (19) |
Caesarean section for severe maternal illness related to COVID-19, n (%) | 3 (9) |
Preterm delivery, n (%) | 1 (3) |
Foetal gender, male, n (%) | 18 (58) |
Birth weight, g, median (range) | 3200 (2180–4165) |
Umbilical artery pH, median (range) | 7.31 (7.14–7.43) |
APGAR score 5’ <7, n (%) | 1 (3) |
Infected neonates, positive, n (%) | 2 (6) |
NICU admission, n (%) | 2 (6) |
Skin to skin, n (%) | 4 (13) |
Breastfeeding, n (%) | 29 (94) |
